(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) | |||
(Address of principal executive offices) | (Zip Code) |
( |
(Registrant’s telephone number, including area code) |
Title of each class | Trading symbol | Name of each exchange on which registered | ||
☒ | Accelerated filer | ☐ | ||
Non-accelerated filer | ☐ | Smaller reporting company | ||
Emerging growth company |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
REVENUE | ||||
Net commissions and fees | $ | $ | ||
Fiduciary investment income | ||||
Total revenue | $ | $ | ||
EXPENSES | ||||
Compensation and benefits | ||||
General and administrative | ||||
Amortization | ||||
Depreciation | ||||
Change in contingent consideration | ( | ( | ||
Total operating expenses | $ | $ | ||
OPERATING INCOME | $ | $ | ||
Interest expense, net | ||||
Income from equity method investment in related party | ( | ( | ||
Other non-operating loss (income) | ( | |||
INCOME BEFORE INCOME TAXES | $ | $ | ||
Income tax expense | ||||
NET INCOME (LOSS) | $( | $ | ||
Net income attributable to non-controlling interests, net of tax | ||||
NET INCOME (LOSS) ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $( | $ | ||
NET INCOME (LOSS) PER SHARE OF CLASS A COMMON STOCK: | ||||
Basic | $( | $ | ||
Diluted | $( | $ | ||
WEIGHTED-AVERAGE SHARES OF CLASS A COMMON STOCK OUTSTANDING: | ||||
Basic | ||||
Diluted |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
NET INCOME (LOSS) | $( | $ | ||
Net income attributable to non-controlling interests, net of tax | ||||
NET INCOME (LOSS) ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $( | $ | ||
Other comprehensive income, net of tax: | ||||
Gain on interest rate cap | ||||
(Gain) on interest rate cap reclassified to earnings | ( | ( | ||
Foreign currency translation adjustments | ( | |||
Change in share of equity method investment in related party other comprehensive income (loss) | ( | |||
Total other comprehensive income, net of tax | $ | $ | ||
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $( | $ |
March 31, 2025 | December 31, 2024 | |||
ASSETS | ||||
CURRENT ASSETS | ||||
Cash and cash equivalents | $ | $ | ||
Commissions and fees receivable – net | ||||
Fiduciary cash and receivables | ||||
Prepaid incentives – net | ||||
Other current assets | ||||
Total current assets | $ | $ | ||
NON-CURRENT ASSETS | ||||
Goodwill | ||||
Customer relationships | ||||
Other intangible assets | ||||
Prepaid incentives – net | ||||
Equity method investment in related party | ||||
Property and equipment – net | ||||
Lease right-of-use assets | ||||
Deferred tax assets | ||||
Other non-current assets | ||||
Total non-current assets | $ | $ | ||
TOTAL ASSETS | $ | $ | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
CURRENT LIABILITIES | ||||
Accounts payable and accrued liabilities | $ | $ | ||
Accrued compensation | ||||
Operating lease liabilities | ||||
Tax Receivable Agreement liabilities | ||||
Short-term debt and current portion of long-term debt | ||||
Fiduciary liabilities | ||||
Total current liabilities | $ | $ | ||
NON-CURRENT LIABILITIES | ||||
Accrued compensation | ||||
Operating lease liabilities | ||||
Long-term debt | ||||
Tax Receivable Agreement liabilities | ||||
Deferred tax liabilities | ||||
Other non-current liabilities | ||||
Total non-current liabilities | $ | $ | ||
TOTAL LIABILITIES | $ | $ | ||
STOCKHOLDERS’ EQUITY | ||||
Class A common stock ($ outstanding at March 31, 2025 and December 31, 2024, respectively) | ||||
Class B common stock ($ outstanding at March 31, 2025 and December 31, 2024, respectively) | ||||
Class X common stock ($ 2025 and December 31, 2024) | ||||
Preferred stock ($ December 31, 2024) | ||||
Additional paid-in capital | ||||
Retained earnings | ||||
Accumulated other comprehensive income (loss) | ( | |||
Total stockholders’ equity attributable to Ryan Specialty Holdings, Inc. | $ | $ | ||
Non-controlling interests | ||||
Total stockholders’ equity | $ | $ | ||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | $ |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||
Net income (loss) | $( | $ | ||
Adjustments to reconcile net income (loss) to cash flows provided by operating activities: | ||||
Income from equity method investment in related party | ( | ( | ||
Amortization | ||||
Depreciation | ||||
Prepaid and deferred compensation expense | ||||
Non-cash equity-based compensation | ||||
Amortization of deferred debt issuance costs | ||||
Amortization of interest rate cap premium | ||||
Deferred income tax expense | ||||
Deferred income tax expense from common control reorganization | ||||
Changes in operating assets and liabilities, net of acquisitions: | ||||
Commissions and fees receivable – net | ( | ( | ||
Accrued interest liability | ( | |||
Other current and non-current assets | ||||
Other current and non-current accrued liabilities | ( | ( | ||
Total cash flows used in operating activities | $( | $( | ||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||
Business combinations – net of cash acquired and cash held in a fiduciary capacity | ( | |||
Capital expenditures | ( | ( | ||
Asset acquisitions | ( | |||
Total cash flows used in investing activities | $( | $( | ||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||
Borrowings on Revolving Credit Facility | ||||
Repayments on Revolving Credit Facility | ( | |||
Debt issuance costs paid | ( | |||
Repayment of term debt | ( | |||
Receipt of contingently returnable consideration | ||||
Payment of contingent consideration | ( | |||
Receipt of taxes related to net share settlement of equity awards | ||||
Taxes paid related to net share settlement of equity awards | ( | ( | ||
Class A common stock dividends and Dividend Equivalents paid | ( | ( | ||
Distributions and Declared Distributions paid to non-controlling LLC Unitholders | ( | ( | ||
Payment of accrued return on Ryan Re preferred units | ( | ( | ||
Net change in fiduciary liabilities | ( | |||
Total cash flows provided by (used in) financing activities | $ | $( | ||
Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ( | |||
NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY | $( | $( | ||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Beginning balance | ||||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Ending balance | $ | $ | ||
Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ||||
Cash and cash equivalents | $ | $ | ||
Cash and cash equivalents held in a fiduciary capacity | ||||
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | $ | $ |
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2024 | $ | $ | $ | $ | $( | $ | $ | |||||||||||
Net income (loss) | — | — | — | — | — | ( | — | ( | ||||||||||
Issuance of common stock | — | — | — | — | — | — | — | — | ||||||||||
Exchange of LLC equity for common stock | ( | — | — | — | ( | |||||||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | ( | ||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment in related party other comprehensive loss | — | — | — | — | — | — | ( | ( | ( | |||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ( | |||||||||||
Balance at March 31, 2025 | $ | $ | $ | $ | $ | $ | $ |
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2023 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | — | — | — | — | — | — | ||||||||||
Exchange of LLC equity for common stock | — | ( | — | — | ( | |||||||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non-controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | — | ( | |||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment in related party other comprehensive income | — | — | — | — | — | — | ||||||||||||
Gain on interest rate cap, net | — | — | — | — | — | — | ||||||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ( | ( | ( | |||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at March 31, 2024 | $ | $ | $ | $ | $ | $ | $ |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
Wholesale Brokerage | $ | $ | ||
Binding Authority | ||||
Underwriting Management | ||||
Total Net commissions and fees | $ | $ |
Velocity | ||
Cash and cash equivalents | $ | |
Commissions and fees receivable – net | ||
Fiduciary cash and receivables | ||
Goodwill | ||
Customer relationships1 | ||
Other intangible assets | ||
Lease right-of-use assets | ||
Other current and non-current assets | ||
Total assets acquired | $ | |
Accounts payable and accrued liabilities | ||
Accrued compensation | ||
Fiduciary liabilities | ||
Operating lease liabilities | ||
Deferred tax liabilities | ||
Total liabilities assumed | $ | |
Net assets acquired | $ |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
Total revenue | $ | $ | ||
Net income (loss) | ( |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
Change in contingent consideration | $( | $( | ||
Interest expense, net | ||||
Total | $( | $ |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
Beginning of period | $ | $ | ||
Write-offs | ( | ( | ||
Increase in provision | ||||
End of period | $ | $ |
March 31, 2025 | December 31, 2024 | |||
Prepaid expenses | $ | $ | ||
Insurance recoverable | ||||
Interest rate cap | ||||
Other current receivables | ||||
Total Other current assets | $ | $ |
Three Months Ended March 31, | |||||
2025 | 2024 | ||||
Lease costs | |||||
Operating lease costs | $ | $ | |||
Short-term lease costs | |||||
Operating lease costs | |||||
Sublease income | ( | ( | |||
Lease costs – net | $ | $ | |||
Cash paid for amounts included in the measurement of lease liabilities | |||||
Operating cash flows for operating leases | $ | $ | |||
Non-cash related activities | |||||
Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
Amortization of right-of-use assets for operating lease activity | |||||
Weighted average discount rate (percent) | |||||
Operating leases | |||||
Weighted average remaining lease term (years) | |||||
Operating leases |
March 31, 2025 | December 31, 2024 | |||
Term debt | ||||
payments, Adjusted Term SOFR + December 31, 2024, matures | $ | $ | ||
Senior secured notes | ||||
mature | ||||
mature August 1, 2032 | ||||
Revolving debt | ||||
SOFR + up to commitment fees of | ||||
Premium financing notes | ||||
Commercial notes, periodic interest and principal payments, expire | ||||
Commercial notes, periodic interest and principal payments, expire | ||||
Commercial notes, periodic interest and principal payments, expire | ||||
Units subject to mandatory redemption | ||||
Total debt | $ | $ | ||
Less: Short-term debt and current portion of long-term debt | ( | ( | ||
Long-term debt | $ | $ |
Three Months Ended March 31, 2025 | |||||||||
Restricted Stock | Weighted Average Grant Date Fair Value | Restricted Common Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | |||||||||
Forfeited | |||||||||
Unvested at end of period | $ | $ |
Three Months Ended March 31, 2025 | |||||||||
IPO RSUs | Incentive RSUs | ||||||||
Restricted Stock Units | Weighted Average Grant Date Fair Value | Restricted Stock Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | ( | ( | |||||||
Forfeited | ( | ( | |||||||
Unvested at end of period | $ | $ |
Three Months Ended March 31, 2025 | |||||||||
Reload Options1 | Staking Options1 | Incentive Options | Incentive Options Weighted Average Exercise Price | ||||||
Outstanding at beginning of period | $ | ||||||||
Granted | |||||||||
Exercised | ( | ||||||||
Forfeited | |||||||||
Outstanding at end of period | $ |
Aggregate intrinsic value ($ in thousands): | ||
Reload Options outstanding | $ | |
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable | ||
Weighted-average remaining contractual term (in years): | ||
Reload Options outstanding | ||
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable | — |
Three Months Ended March 31, 2025 | |||||||||
IPO RLUs | Incentive RLUs | ||||||||
Restricted LLC Units | Weighted Average Grant Date Fair Value | Restricted LLC Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | |||||||||
Forfeited | |||||||||
Unvested at end of period | $ | $ |
Three Months Ended March 31, 2025 | |||||||||
Reload Class C Incentive Units | Staking Class C Incentive Units | Class C Incentive Units | Class C Incentive Units Weighted Average Participation Threshold | ||||||
Unvested at beginning of period | $ | ||||||||
Granted | |||||||||
Vested | |||||||||
Forfeited | |||||||||
Unvested at end of period | $ |
Three Months Ended March 31, 2025 | |||||||||
PSUs | PLUs | ||||||||
Performance Stock Units | Weighted Average Grant Date Fair Value | Performance LLC Units | Weighted Average Grant Date Fair Value | ||||||
Unvested at beginning of period | $ | $ | |||||||
Granted | |||||||||
Vested | |||||||||
Forfeited | |||||||||
Unvested at end of period | $ | $ |
Volatility | ||
Time to maturity (years) | ||
Risk-free rate | ||
RYAN stock price at valuation date | $ |
Amount | Weighted Average Remaining Expense Period (Years) | |||
Restricted Stock | $ | |||
IPO RSUs | ||||
Incentive RSUs | ||||
Reload Options | ||||
Staking Options | ||||
Incentive Options | ||||
PSUs | ||||
Restricted Common Units | ||||
IPO RLUs | ||||
Incentive RLUs | ||||
Reload Class C Incentive Units | ||||
Staking Class C Incentive Units | ||||
Class C Incentive Units | ||||
PLUs | ||||
Total unrecognized equity-based compensation expense | $ |
Recognized | Unrecognized | |||||
Three Months Ended March 31, | As of March 31, 2025 | |||||
2025 | 2024 | |||||
IPO awards | ||||||
IPO RSUs and Staking Options | $ | $ | $ | |||
IPO RLUs and Staking Class C Incentive Units | ||||||
Incremental Restricted Stock and Reload Options | ||||||
Incremental Restricted Common Units and Reload Class C Incentive Units | ||||||
Pre-IPO incentive awards | ||||||
Restricted Stock | ||||||
Restricted Common Units | ||||||
Post-IPO incentive awards | ||||||
Incentive RSUs | ||||||
Incentive RLUs | ||||||
Incentive Options | ||||||
Class C Incentive Units | ||||||
PSUs | ||||||
PLUs | ||||||
Other expense | ||||||
Director Stock Grants | ||||||
Total equity-based compensation expense | $ | $ | $ |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
Net income (loss) | $( | $ | ||
Less: Net income attributable to non-controlling interests | ||||
Net income (loss) attributable to Ryan Specialty Holdings, Inc. | $( | $ | ||
Numerator: | ||||
Net income (loss) attributable to Class A common shareholders | $( | $ | ||
Less: Income attributed to substantively vested RSUs | ( | |||
Net income (loss) attributable to Class A common shareholders – basic | $( | $ | ||
Add: Income attributed to dilutive shares | ||||
Net income (loss) attributable to Class A common shareholders – diluted | $( | $ | ||
Denominator: | ||||
Weighted-average shares of Class A common stock outstanding – basic | ||||
Add: Dilutive shares | ||||
Weighted-average shares of Class A common stock outstanding – diluted | ||||
Earnings (loss) per share | ||||
Earnings (loss) per share of Class A common stock – basic | $( | $ | ||
Earnings (loss) per share of Class A common stock – diluted | $( | $ |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
Conversion of non-controlling interest LLC Common Units1 | ||||
Restricted Stock | ||||
IPO RSUs | ||||
Incentive RSUs | ||||
Incentive PSUs | ||||
Reload Options | ||||
Staking Options | ||||
Incentive Options | ||||
Restricted Common Units | ||||
IPO RLUs | ||||
Incentive RLUs | ||||
Incentive PLUs | ||||
Reload Class C Incentive Units | ||||
Staking Class C Incentive Units | ||||
Class C Incentive Units |
Three Months Ended March 31, | |||||
Income Statement Caption | 2025 | 2024 | |||
Change in the fair value of the Deal-Contingent Forward | General and administrative | $ | $( | ||
Total impact of derivatives not designated as hedging instruments | $ | $( | |||
Interest rate cap premium amortization | Interest expense, net | $( | $( | ||
Amounts reclassified out of other comprehensive income related to the interest rate cap | Interest expense, net | ||||
Total impact of derivatives designated as hedging instruments | $ | $ |
Balance Sheet Caption | March 31, 2025 | December 31, 2024 | |||
Interest rate cap | Other current assets | $ | $ |
March 31, 2025 | December 31, 2024 | |||||||||||
Level 1 | Level 2 | Level 3 | Level 1 | Level 2 | Level 3 | |||||||
Assets | ||||||||||||
Interest rate cap | $ | $ | $ | $ | $ | $ | ||||||
Contingently returnable consideration | ||||||||||||
Liabilities | ||||||||||||
Contingent consideration | ||||||||||||
Total assets and liabilities measured at fair value | $ | $ | $ | $ | $ | $ |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
Assets | ||||
Balance at beginning of period | $ | $ | ||
Total gains included in earnings | ||||
Total gains included in OCI | ||||
Settlements | ( | |||
Balance at end of period | $ | $ | ||
Liabilities | ||||
Balance at beginning of period | $ | $ | ||
Newly established liability due to acquisitions | ||||
Total (gains) losses included in earnings | ( | |||
Settlements | ( | |||
Acquisition measurement period adjustments | ||||
Balance at end of period | $ | $ |
Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | |||||
Balance at December 31, 2024 | $ | $ | $ | $ | ||||
Exchange of LLC Common Units | ||||||||
Balance at March 31, 2025 | $ | $ | $ | $ |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
Gain on interest rate cap | $( | $( | ||
Gain on interest rate cap reclassified to earnings | ||||
Foreign currency translation adjustments | ( | |||
Change in share of equity method investment in related party | ( |
Gain on Interest Rate Cap | Foreign Currency Translation Adjustments | Change in EMI Other Comprehensive Loss 1 | Total | |||||
Balance at December 31, 2024 | $ | $( | $( | $( | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $( | $ | ||||
Less: Non-controlling interests | ( | ( | ||||||
Balance at March 31, 2025 | $ | $ | $( | $ |
Gain on Interest Rate Cap | Foreign Currency Translation Adjustments | Change in EMI Other Comprehensive Income (Loss) 1 | Total | |||||
Balance at December 31, 2023 | $ | $ | $( | $ | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $ | $( | $ | $ | ||||
Less: Non-controlling interests | ( | |||||||
Balance at March 31, 2024 | $ | $ | $( | $ |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
Net commissions and fees | $ | $ | ||
Fiduciary investment income | ||||
Total revenue | $ | $ | ||
Compensation-related expense1 | ||||
General and administrative expense2 | ||||
Other segment items3 | ||||
Depreciation and amortization | ||||
Change in contingent consideration | ( | ( | ||
Interest income | ( | ( | ||
Interest expense | ||||
Income from equity method investment in related party | ( | ( | ||
Income tax expense | ||||
Other non-operating loss (income) | ( | |||
Net income (loss) | $( | $ |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
United States | $ | $ | ||
Foreign | ||||
Total revenue | $ | $ |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
Cash paid for: | ||||
Interest, net1 | $ | $ | ||
Income taxes, net of refunds | ||||
Non-cash investing and financing activities: | ||||
Non-controlling interest holders’ tax distributions declared but unpaid | $ | $ | ||
Tax Receivable Agreement liabilities | ||||
Dividend Equivalents and Declared Distributions liabilities | ||||
Contingent consideration liabilities |
Three Months Ended March 31, | Change | |||||||
(in thousands, except percentages and per share data) | 2025 | 2024 | $ | % | ||||
Revenue | ||||||||
Net commissions and fees | $676,128 | $537,887 | $138,241 | 25.7 % | ||||
Fiduciary investment income | 14,038 | 14,159 | (121) | (0.9) | ||||
Total revenue | $690,166 | $552,046 | $138,120 | 25.0 % | ||||
Expenses | ||||||||
Compensation and benefits | 430,289 | 373,527 | 56,762 | 15.2 | ||||
General and administrative | 106,060 | 75,867 | 30,193 | 39.8 | ||||
Amortization | 64,985 | 27,988 | 36,997 | NM | ||||
Depreciation | 2,639 | 2,080 | 559 | 26.9 | ||||
Change in contingent consideration | (14,042) | (65) | (13,977) | NM | ||||
Total operating expenses | $589,931 | $479,397 | $110,534 | 23.1 % | ||||
Operating income | $100,235 | $72,649 | $27,586 | 38.0 % | ||||
Interest expense, net | 54,508 | 29,400 | 25,108 | 85.4 | ||||
(Income) from equity method investment in related party | (4,937) | (5,606) | 669 | (11.9) | ||||
Other non-operating loss (income) | (377) | 1,752 | (2,129) | NM | ||||
Income before income taxes | $51,041 | $47,103 | $3,938 | 8.4 % | ||||
Income tax expense | 55,430 | 6,426 | 49,004 | NM | ||||
Net income (loss) | $(4,389) | $40,677 | $(45,066) | NM | ||||
GAAP financial measures | ||||||||
Total revenue | $690,166 | $552,046 | $138,120 | 25.0 % | ||||
Net commissions and fees | 676,128 | 537,887 | 138,241 | 25.7 | ||||
Compensation and benefits | 430,289 | 373,527 | 56,762 | 15.2 | ||||
General and administrative | 106,060 | 75,867 | 30,193 | 39.8 | ||||
Net income (loss) | (4,389) | 40,677 | (45,066) | NM | ||||
Compensation and benefits expense ratio (1) | 62.3 % | 67.7 % | ||||||
General and administrative expense ratio (2) | 15.4 % | 13.7 % | ||||||
Net income (loss) margin (3) | (0.6)% | 7.4 % | ||||||
Earnings (loss) per share (4) | $(0.22) | $0.14 | ||||||
Diluted earnings (loss) per share (4) | $(0.22) | $0.13 | ||||||
Non-GAAP financial measures* | ||||||||
Organic revenue growth rate | 12.9 % | 13.7 % | ||||||
Adjusted compensation and benefits expense | $397,428 | $330,022 | $67,406 | 20.4% | ||||
Adjusted compensation and benefits expense ratio | 57.6 % | 59.8 % | ||||||
Adjusted general and administrative expense | $92,237 | $64,802 | $27,435 | 42.3% | ||||
Adjusted general and administrative expense ratio | 13.4 % | 11.7 % | ||||||
Adjusted EBITDAC | $200,501 | $157,222 | $43,279 | 27.5% | ||||
Adjusted EBITDAC margin | 29.1 % | 28.5 % | ||||||
Adjusted net income | $107,839 | $95,417 | $12,422 | 13.0% | ||||
Adjusted net income margin | 15.6 % | 17.3 % | ||||||
Adjusted diluted earnings per share | $0.39 | $0.35 | $0.04 | 11.4% |
Three Months Ended March 31, | ||||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Wholesale Brokerage | $360,788 | 53.4 % | $323,445 | 60.1 % | $37,343 | 11.5 % | ||||||
Binding Authorities | 101,950 | 15.1 | 88,635 | 16.5 | 13,315 | 15.0 | ||||||
Underwriting Management | 213,390 | 31.5 | 125,807 | 23.4 | 87,583 | 69.6 | ||||||
Total net commissions and fees | $676,128 | $537,887 | $138,241 | 25.7 % | ||||||||
Three Months Ended March 31, | ||||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Net commissions and policy fees | $623,966 | 92.3 % | $494,445 | 91.9 % | $129,521 | 26.2 % | ||||||
Supplemental and contingent commissions | 37,773 | 5.6 | 29,256 | 5.5 | 8,517 | 29.1 | ||||||
Loss mitigation and other fees | 14,389 | 2.1 | 14,186 | 2.6 | 203 | 1.4 | ||||||
Total net commissions and fees | $676,128 | $537,887 | $138,241 | 25.7 % |
Three Months Ended March 31, | ||||
(in thousands, except percentages) | 2025 | 2024 | ||
Current period Net commissions and fees revenue | $676,128 | $537,887 | ||
Less: Current period contingent commissions | (30,463) | (24,503) | ||
Less: Revenue attributable to sold businesses | (146) | — | ||
Net Commissions and fees revenue excluding contingent commissions | $645,519 | $513,385 | ||
Prior period Net commissions and fees revenue | $537,887 | $447,513 | ||
Less: Prior year contingent commissions | (24,503) | (21,635) | ||
Less: Revenue attributable to sold businesses | (539) | — | ||
Prior period Net commissions and fees revenue excluding contingent commissions | $512,845 | $425,878 | ||
Change in Net commissions and fees revenue excluding contingent commissions | $132,674 | $87,507 | ||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions | (67,155) | (28,539) | ||
Impact of change in foreign exchange rates | 430 | (323) | ||
Organic revenue growth (Non-GAAP) | $65,949 | $58,644 | ||
Net commissions and fees revenue growth rate (GAAP) | 25.7 % | 20.2 % | ||
Less: Impact of contingent commissions (1) | 0.2 | 0.3 | ||
Net commissions and fees revenue excluding contingent commissions growth rate (2) | 25.9 % | 20.5 % | ||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions (3) | (13.1) | (6.7) | ||
Impact of change in foreign exchange rates (4) | 0.1 | (0.1) | ||
Organic Revenue Growth Rate (Non-GAAP) | 12.9 % | 13.7 % |
Three Months Ended March 31, | ||||
(in thousands, except percentages) | 2025 | 2024 | ||
Total revenue | $690,166 | $552,046 | ||
Compensation and benefits expense | $430,289 | $373,527 | ||
Acquisition-related expense | (3,479) | (226) | ||
Acquisition related long-term incentive compensation | (8,331) | 1,627 | ||
Restructuring and related expense | — | (26,184) | ||
Amortization and expense related to discontinued prepaid incentives | (1,178) | (1,412) | ||
Equity-based compensation | (14,569) | (9,515) | ||
Initial public offering related expense | (5,304) | (7,795) | ||
Adjusted compensation and benefits expense (1) | $397,428 | $330,022 | ||
Compensation and benefits expense ratio | 62.3 % | 67.7 % | ||
Adjusted compensation and benefits expense ratio | 57.6 % | 59.8 % |
Three Months Ended March 31, | ||||
(in thousands, except percentages) | 2025 | 2024 | ||
Total revenue | $690,166 | $552,046 | ||
General and administrative expense | $106,060 | $75,867 | ||
Acquisition-related expense | (13,823) | (8,211) | ||
Restructuring and related expense | — | (2,854) | ||
Adjusted general and administrative expense (1) | $92,237 | $64,802 | ||
General and administrative expense ratio | 15.4 % | 13.7 % | ||
Adjusted general and administrative expense ratio | 13.4 % | 11.7 % |
Three Months Ended March 31, | ||||
(in thousands, except percentages) | 2025 | 2024 | ||
Total revenue | $690,166 | $552,046 | ||
Net income (loss) | $(4,389) | $40,677 | ||
Interest expense, net | 54,508 | 29,400 | ||
Income tax expense | 55,430 | 6,426 | ||
Depreciation | 2,639 | 2,080 | ||
Amortization | 64,985 | 27,988 | ||
Change in contingent consideration (1) | (14,042) | (65) | ||
EBITDAC | $159,131 | $106,506 | ||
Acquisition-related expense | 17,302 | 8,437 | ||
Acquisition related long-term incentive compensation | 8,331 | (1,627) | ||
Restructuring and related expense | — | 29,038 | ||
Amortization and expense related to discontinued prepaid incentives | 1,178 | 1,412 | ||
Other non-operating loss (income) | (377) | 1,752 | ||
Equity-based compensation | 14,569 | 9,515 | ||
IPO related expenses | 5,304 | 7,795 | ||
(Income) from equity method investments in related party | (4,937) | (5,606) | ||
Adjusted EBITDAC | $200,501 | $157,222 | ||
Net income (loss) margin | (0.6)% | 7.4 % | ||
Adjusted EBITDAC margin | 29.1 % | 28.5 % |
Three Months Ended March 31, | ||||
(in thousands, except percentages) | 2025 | 2024 | ||
Total revenue | $690,166 | $552,046 | ||
Net income (loss) | $(4,389) | $40,677 | ||
Income tax expense | 55,430 | 6,426 | ||
Amortization | 64,985 | 27,988 | ||
Amortization of deferred debt issuance costs (1) | 2,374 | 3,409 | ||
Change in contingent consideration | (14,042) | (65) | ||
Acquisition-related expense | 17,302 | 8,437 | ||
Acquisition related long-term incentive compensation | 8,331 | (1,627) | ||
Restructuring and related expense | — | 29,038 | ||
Amortization and expense related to discontinued prepaid incentives | 1,178 | 1,412 | ||
Other non-operating loss (income) | (377) | 1,752 | ||
Equity-based compensation | 14,569 | 9,515 | ||
IPO related expenses | 5,304 | 7,795 | ||
(Income) from equity method investments in related party | (4,937) | (5,606) | ||
Adjusted income before income taxes (2) | $145,728 | $129,151 | ||
Adjusted income tax expense (3) | (37,889) | (33,734) | ||
Adjusted net income | $107,839 | $95,417 | ||
Net income (loss) margin | (0.6)% | 7.4 % | ||
Adjusted net income margin | 15.6 % | 17.3 % |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
Earnings (loss) per share of Class A common stock – diluted | $(0.22) | $0.13 | ||
Less: Net income attributed to dilutive shares and substantively vested RSUs (1) | — | (0.07) | ||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | 0.20 | 0.09 | ||
Plus: Adjustments to Adjusted net income (3) | 0.43 | 0.20 | ||
Plus: Dilutive impact of unvested equity awards (4) | (0.02) | — | ||
Adjusted diluted earnings per share | $0.39 | $0.35 | ||
(Share count in ’000) | ||||
Weighted-average shares of Class A common stock outstanding – diluted | 125,420 | 269,922 | ||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | 136,064 | — | ||
Plus: Dilutive impact of unvested equity awards (4) | 17,783 | 4,854 | ||
Adjusted diluted earnings per share diluted share count | 279,267 | 274,776 |
(in thousands) | Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | ||||
Balance at December 31, 2024 | $253,233 | $83,415 | $99,648 | $436,296 | ||||
Exchange of LLC Common Units | 7,994 | 627 | 2,469 | 11,090 | ||||
Balance at March 31, 2025 | $261,227 | $84,042 | $102,117 | $447,386 |
Long-term Incentive Compensation Agreements | ||
(in thousands) | March 31, 2025 | |
Current accrued compensation | $11,869 | |
Non-current accrued compensation | 15,424 | |
Total liability | $27,293 | |
Projected future expense | 34,414 | |
Total projected future cash outflows | $61,707 |
Projected Future Cash Outflows | ||
(in thousands) | ||
2025 | $11,677 | |
2026 | 6,771 | |
2027 | 14,605 | |
2028 | 28,603 | |
Thereafter | $51 |
Contingent Consideration | ||
(in thousands) | March 31, 2025 | |
Current accounts payable and accrued liabilities | $5,614 | |
Other non-current liabilities | 90,719 | |
Total liability | $96,333 | |
Projected future expense | 11,756 | |
Total projected future cash outflows | $108,089 |
Projected Future Cash Outflows | ||
(in thousands) | ||
2025 | $5,539 | |
2026 | 17,853 | |
2027 | 84,696 | |
2028 | — | |
Thereafter | $— |
(in thousands) | Balance at March 31, 2025 | 100 BPS Increase | 100 BPS Decrease | |||
Cash and cash equivalents | $203,549 | $(2,035) | $2,035 | |||
Term Loan principal outstanding (1) | 1,695,800 | 16,958 | (16,958) | |||
Interest rate cap notional amount (2) | 1,000,000 | (10,000) | 10,000 | |||
Net exposure to Interest expense, net | $4,923 | $(4,923) | ||||
Cash and cash equivalents held in a fiduciary capacity | 1,108,317 | 11,083 | $(11,083) | |||
Net exposure to Fiduciary investment income | $11,083 | $(11,083) | ||||
Impact to Net income | $6,161 | $(6,161) |
Exhibit Number | Description | |
3.1 | ||
3.2 | ||
3.3 | ||
4.1 | ||
4.2 | ||
4.3 | ||
4.4 | ||
4.5 | ||
4.6 | ||
10.1 | ||
10.2 | ||
10.3 | ||
10.4 | ||
10.5 | ||
10.6 | ||
10.7 | ||
10.8 | ||
10.9 | ||
10.10 | ||
10.11 | ||
10.12 | ||
10.13 | ||
10.14 | ||
10.15 | ||
10.16 | ||
10.17 | ||
10.18 | ||
10.19 | ||
19.1 | ||
31.1 | ||
31.2 | ||
32.1* | ||
32.2* | ||
97.1 | ||
101.INS | Inline XBRL (Extensible Business Reporting Language) Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | |
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
RYAN SPECIALTY HOLDINGS, INC. (Registrant) | ||
Date: May 1, 2025 | By: | /s/ Janice M. Hamilton |
Janice M. Hamilton | ||
Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |